Bio-Techne Corp
TECH65.850USD
+2.360+3.72%
종가 11/25, 16:00（ET）시세는 15분 지연됩니다
10.26B시가총액
131.57P/E TTM
자세한 내용은 Bio-Techne Corp 회사
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.
Bio-Techne Corp 정보
종목 코드 TECH
회사 이름Bio-Techne Corp
상장일Feb 09, 1989
CEOMr. Kim Kelderman
직원 수3100
유형Ordinary Share
회계 연도 종료Feb 09
주소614 Mckinley Pl N E
도시MINNEAPOLIS
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호55413
전화16123792956
웹사이트https://www.bio-techne.com/
종목 코드 TECH
상장일Feb 09, 1989
CEOMr. Kim Kelderman
Bio-Techne Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.51%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
48.66K
-4.52%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.66%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+11.91%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+17.55%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+22.99%
Dr. Matthew F. Mcmanus
Dr. Matthew F. Mcmanus
President - Diagnostics and Spatial Biology
President - Diagnostics and Spatial Biology
4.74K
+169.49%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
4.38K
--
Dr. Judith V. Klimovsky, M.D.
Dr. Judith V. Klimovsky, M.D.
Independent Director
Independent Director
3.78K
+76.56%
Mr. James T. (Jim) Hippel
Mr. James T. (Jim) Hippel
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.51%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
48.66K
-4.52%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.66%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+11.91%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+17.55%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+22.99%
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Consumables
972.29M
79.72%
Instruments
112.09M
9.19%
Service
111.57M
9.15%
Royalty
23.69M
1.94%
지역별USD
이름
수익
비율
United States
683.23M
56.02%
EMEA, excluding U.K
266.31M
21.83%
Greater China
100.46M
8.24%
APAC, excluding Greater China
77.26M
6.33%
United Kingdom
54.83M
4.50%
Rest of World
37.55M
3.08%
사업별
지역별
사업별USD
이름
수익
비율
Consumables
972.29M
79.72%
Instruments
112.09M
9.19%
Service
111.57M
9.15%
Royalty
23.69M
1.94%
주식 보유 통계
마지막 업데이트: Sun, Nov 16
마지막 업데이트: Sun, Nov 16
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
11.48%
BlackRock Institutional Trust Company, N.A.
5.64%
State Street Investment Management (US)
3.69%
Wellington Management Company, LLP
3.28%
Atlanta Capital Management Company, L.L.C.
3.17%
기타
72.73%
주주
주주
비율
The Vanguard Group, Inc.
11.48%
BlackRock Institutional Trust Company, N.A.
5.64%
State Street Investment Management (US)
3.69%
Wellington Management Company, LLP
3.28%
Atlanta Capital Management Company, L.L.C.
3.17%
기타
72.73%
주주 유형
주주
비율
Investment Advisor
57.86%
Investment Advisor/Hedge Fund
34.00%
Hedge Fund
8.05%
Bank and Trust
2.18%
Research Firm
1.96%
Pension Fund
1.33%
Sovereign Wealth Fund
1.24%
Individual Investor
0.28%
Insurance Company
0.24%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
1198
161.18M
103.53%
-7.34M
2025Q2
1209
165.25M
105.41%
-730.33K
2025Q1
1245
168.10M
107.22%
+1.54M
2024Q4
1233
162.21M
102.61%
-6.39M
2024Q3
1205
159.40M
100.49%
-10.21M
2024Q2
1207
160.52M
101.86%
-12.24M
2024Q1
1216
162.56M
103.40%
-7.57M
2023Q4
1229
159.70M
100.98%
-3.97M
2023Q3
1217
156.41M
98.84%
-7.93M
2023Q2
1213
155.36M
98.68%
-4.04M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
18.40M
11.82%
-60.83K
-0.33%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
8.79M
5.65%
-512.26K
-5.50%
Jun 30, 2025
State Street Investment Management (US)
5.86M
3.76%
-671.30K
-10.28%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
4.29M
2.76%
+573.23K
+15.41%
Jun 30, 2025
Geode Capital Management, L.L.C.
4.06M
2.61%
-30.89K
-0.75%
Jun 30, 2025
Invesco Capital Management LLC
3.24M
2.08%
+274.96K
+9.28%
Jun 30, 2025
Neuberger Berman, LLC
2.50M
1.61%
-526.06K
-17.38%
Jun 30, 2025
T. Rowe Price Associates, Inc.
8.62M
5.53%
-2.53M
-22.68%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Thu, Nov 6
마지막 업데이트: Thu, Nov 6
이름
비율
Global X Genomics & Biotechnology ETF
3.95%
Invesco Biotechnology & Genome ETF
2.62%
Invesco S&P 500 Equal Weight Health Care ETF
1.79%
VanEck Biotech ETF
1.63%
Neuberger Berman Small-Mid Cap ETF
1.58%
Hilton Small-MidCap Opportunity ETF
1.55%
Thrivent Small-Mid Cap ESG ETF
1.44%
American Century Mid Cap Growth Impact ETF
1.39%
WisdomTree BioRevolution Fund
1.22%
iShares Health Innovation Active ETF
1.2%
더 보기
Global X Genomics & Biotechnology ETF
비율3.95%
Invesco Biotechnology & Genome ETF
비율2.62%
Invesco S&P 500 Equal Weight Health Care ETF
비율1.79%
VanEck Biotech ETF
비율1.63%
Neuberger Berman Small-Mid Cap ETF
비율1.58%
Hilton Small-MidCap Opportunity ETF
비율1.55%
Thrivent Small-Mid Cap ESG ETF
비율1.44%
American Century Mid Cap Growth Impact ETF
비율1.39%
WisdomTree BioRevolution Fund
비율1.22%
iShares Health Innovation Active ETF
비율1.2%
주식 배당금
지난 5년 동안 총
250.90M
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Feb 05, 2025
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025
Feb 17, 2025
Feb 28, 2025
Feb 14, 2025
Oct 30, 2024
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024
Nov 11, 2024
Nov 22, 2024
Nov 08, 2024
Aug 07, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024
Aug 19, 2024
Aug 30, 2024
Aug 19, 2024
May 01, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024
May 13, 2024
May 24, 2024
May 10, 2024
Feb 01, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024
Feb 12, 2024
Feb 26, 2024
Feb 09, 2024
Oct 31, 2023
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 24, 2023 going ex on Nov 09, 2023
Nov 10, 2023
Nov 24, 2023
Nov 09, 2023
Aug 08, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Sep 01, 2023 going ex on Aug 17, 2023
Aug 18, 2023
Sep 01, 2023
Aug 17, 2023
May 03, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 26, 2023 going ex on May 12, 2023
May 15, 2023
May 26, 2023
May 12, 2023
Feb 02, 2023
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 27, 2023 going ex on Feb 10, 2023
Feb 13, 2023
Feb 27, 2023
Feb 10, 2023
Nov 01, 2022
TECH.NB Final Cash Dividend of gross USD 0.32 paid on Nov 28, 2022 going ex on Nov 10, 2022
Nov 14, 2022
Nov 28, 2022
Nov 10, 2022
더 보기
주식 분할
날짜
유형
비율
Nov 01, 2022
Split
1→4
날짜
유형
비율
Nov 01, 2022
Split
1→4
자주 묻는 질문
Bio-Techne Corp의 상위 5대 주주는 누구인가요?
Bio-Techne Corp의 상위 5대 주주는 다음과 같습니다:
The Vanguard Group, Inc.는 18.40M주의 주식을 보유하고 있으며, 전체 주식의 11.82%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 8.79M주의 주식을 보유하고 있으며, 전체 주식의 5.65%를 차지합니다.
State Street Investment Management (US)는 5.86M주의 주식을 보유하고 있으며, 전체 주식의 3.76%를 차지합니다.
Atlanta Capital Management Company, L.L.C.는 4.29M주의 주식을 보유하고 있으며, 전체 주식의 2.76%를 차지합니다.
Geode Capital Management, L.L.C.는 4.06M주의 주식을 보유하고 있으며, 전체 주식의 2.61%를 차지합니다.
The Vanguard Group, Inc.는 18.40M주의 주식을 보유하고 있으며, 전체 주식의 11.82%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 8.79M주의 주식을 보유하고 있으며, 전체 주식의 5.65%를 차지합니다.
State Street Investment Management (US)는 5.86M주의 주식을 보유하고 있으며, 전체 주식의 3.76%를 차지합니다.
Atlanta Capital Management Company, L.L.C.는 4.29M주의 주식을 보유하고 있으며, 전체 주식의 2.76%를 차지합니다.
Geode Capital Management, L.L.C.는 4.06M주의 주식을 보유하고 있으며, 전체 주식의 2.61%를 차지합니다.
Bio-Techne Corp의 상위 3대 주주 유형은 무엇인가요?
Bio-Techne Corp의 주요 주주 유형 상위 3가지는
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)입니다.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)입니다.
Bio-Techne Corp(TECH)의 주식을 보유한 기관은 몇 개입니까?
2025Q3 기준으로, Bio-Techne Corp의 주식을 보유한 기관은 총 1198곳이며, 이들이 보유한 주식의 총 가치는 약 161.18M로 전체 발행 주식의 103.53%를 차지합니다. 이는 2025Q2 대비 -1.88% 증가한 수치입니다.
Bio-Techne Corp의 최대 수익원은 무엇인가요?
FY2025 기준, Bio-Techne Corp의 Consumables 부문이 가장 높은 매출을 기록했으며, 금액은 972.29M로 전체 매출의 79.72%를 차지했습니다.
